Holen Sie sich die Stockscreener-App
1.04
1.89%
-0.02
Handel nachbörslich:
1.06
0.02
+1.92%
Ww International Inc Aktie (WW) Neueste Nachrichten
WeightWatchers' CEO embraced Ozempic. Now she's out of the company. - AOL
WW (WW International) GF Score : 51/100 (As of Oct. 30, 2024) - GuruFocus.com
WW (WW International) Profitability Rank : 6 (As of Jun. 2024) - GuruFocus.com
WW International (WW) Scheduled to Post Earnings on Wednesday - MarketBeat
WW International, Inc. (NASDAQ:WW) Short Interest Up 20.4% in October - MarketBeat
WeightWatchers cashes in on popularity of weight loss drugs with compounded semaglutide - MSN
WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call - The Manila Times
Weight Loss Services Market Analysis Report 2024-2030, Featuring Profiles of Atkins Nutritionals, Precor, Apollo Endosurgery, Johnson Health Tech, Life Fitness, iFIT, Torque Fitness and More - GlobeNewswire Inc.
WW International, Inc. (NASDAQ:WW) Receives $4.50 Consensus Target Price from Analysts - MarketBeat
WW International (WW) Stock Rises on Potential Reconsideration o - GuruFocus.com
WW surge after GLP-1 compounding announcement not justified after study, Barclays says - MSN
WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model' - Yahoo Finance
WW International (NASDAQ:WW) Given Underweight Rating at Barclays - MarketBeat
A company insider recently bought 64,500 shares of WW International Inc [WW]. Should You Buy? - Knox Daily
Analysts Reiterate Negative Outlook on WeightWatchers (NASDAQ:WW) Stock - TipRanks
Weight Watchers Stock Rises 38% On Plan To Sell Obesity Drugs - Baystreet.ca
WW International: The Party Won't Last Long (NASDAQ:WW) - Seeking Alpha
WW Stock Rises as WeightWatchers Expands Drug Offerings - GuruFocus.com
WW International Inc (WW) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
WW International Inc (WW) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
WeightWatchers (NASDAQ:WW) Stock Jumps 40% on Plan to Sell Obesity Medications - TipRanks
Why Are WeightWatchers (WW) Shares Soaring Today - Yahoo Finance
WW International surges as Morgan Stanley says GLP-1 entry 'not too late' - MSN
Traders Purchase High Volume of Call Options on WW International (NASDAQ:WW) - MarketBeat
Perhaps timely catching WW International Inc (WW) would be a good idea - SETE News
WW International (WW) Surges After Introducing Compounded Semagl - GuruFocus.com
WW International surges as Morgan Stanley says GLP-1 entry 'not too late' (WW) - Seeking Alpha
What's Going With WeightWatchers Stock On Wednesday? - Yahoo Finance
Market Analysts see WW International Inc [WW] falling to $1.25. Time to buy? - The DBT News
WW International, Inc. (NASDAQ:WW) Stock Catapults 54% Though Its Price And Business Still Lag The Industry - Simply Wall St
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy - Fast Company
WW International shares face pressure as Barclays flags concerns over long-term viability of compounding - Investing.com South Africa
WW’s Stock Journey: What Investors Need to Know About WW International Inc’s Performance - The InvestChronicle
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering - Investopedia
WeightWatchers stock pops on compounded GLP-1 weight-loss medication - Yahoo Finance
WeightWatchers Jumps on Offer to Sell Low-Cost Wegovy Copy - Bloomberg
WeightWatchers adds semaglutide for weight management By Investing.com - Investing.com UK
WeightWatchers’ stock soars after adding compounded GLP-1 treatment to offering - MarketWatch
3.61%
14.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):